Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies

Authors: Christophe Le Tourneau, Sandrine Faivre, Valérie Laurence, Catherine Delbaldo, Karina Vera, Véronique Girre, Judy H. Chiao, Sian Armour, Sheelagh Frame, Simon R. Green, Athos Gianella-Borradori, Véronique Dièras, Éric Raymond - European Journal of Cancer 2010 cited by 167